Skip to content

A Smart Polypeptide-Based Photoresponsive Nanotherapeutic against Methicillin-Resistant Staphylococcus aureus.

Aug 2026 · ACS Applied Bio Materials · Vol 9 16, pp. 7269-7283 · 0 citations · 67 references
Medicine

TL;DR

The present study suggests that photo-responsive polypeptide PNFs represent a promising and versatile therapeutic strategy for combating antibiotic-resistant bacterial infections, owing to their dual functional capabilities.

Abstract

Therapeutic interventions for bacterial infections are increasingly challenging due to the growing threat of antibiotic resistance, particularly from Methicillin-resistant Staphylococcus aureus (MRSA), which poses significant risks to global health. Generally, MRSA has a high mortality rate and can lead to severe illnesses such as sepsis and pneumonia, mainly due to the lack of effective treatments and growing drug resistance. To this end, the present study introduces azobenzene-conjugated photo-responsive polypeptide nanofibers (PNFs) that mimic host-defense peptides to combat antibiotic-resistant bacterial pathogens. We show that incorporating an azobenzene moiety into the PNF enables light-mediated control via photoinduced conformational changes. The polypeptide structure incorporates these azobenzene units, synthesized via ring-opening polymerization (ROP) of N-carbobenzoxy-l-lysine N-carboxyanhydride (Cbz-l-Lys NCA) with NAP-AZO as the initiator. Moreover, we show that conformational changes in the PNF affect its interactions with bacterial membranes. While the azobenzene moieties provide light-regulated activity, the amino groups from lysine enhance electrostatic membrane disruption. This has resulted in effective membrane interaction of PNFs, facilitating the generation of reactive oxygen species (ROS) against MRSA, which are crucial for bacterial death or growth inhibition. Overall, the present study suggests that photo-responsive polypeptide PNFs represent a promising and versatile therapeutic strategy for combating antibiotic-resistant bacterial infections, owing to their dual functional capabilities.

View source

Similar papers

Jul 2026

Quaternary Ammonium-Functionalized Membrane-Anchored Photosensitizer against Multidrug-Resistant Bacterial Infections.

In an MRSA-infected wound model, PK4-mediated phototherapy can reduce inflammation, accelerate wound healing, and enhance collagen deposition without systemic toxicity, providing a promising aPDT strategy for combating drug-resistant bacterial infections.

Yan Zeng, Huijiao Tang, Xinyu Wu et al. · 0 citations
Open access Jul 2026

Glycan-decorated polymeric nanomedicine for the treatment of multidrug-resistant infections

A hierarchical, stimuli-responsive nanomedicine designed on principles of safety, specificity, switchability, and synergy is reported, offering a universal strategy to treat diverse, multidrug-resistant infections.

R. Gao, Hongbing Liu, Wan-Bo Zhu et al. · 0 citations
Jul 2026

Antibacterial peptide nanofibrils for targeted elimination of drug-resistant Staphylococci.

Self-assembling, tryptophan-rich peptide nanofibrils derived from DVFLGREEWWWWC (D4W) are introduced as potent antibacterial agents against Staphylococcus species, including MRSA, and their efficacy was validated in ex vivo pig skin and in vivo zebrafish embryo models.

Suchita Paul, Wei-Yu Wang, Yu-Chun Hsiao et al. · 0 citations
Jul 2026

Antibacterial photoswitchable triazenic ciprofloxacins

The determination and comparison of the MIC50 values of the selected TC compounds identified molecules exhibiting increased activity resulting from a conformational change under UVA exposure.

Amélie Aubert, A. Fayeulle, M. Vayssade et al. · 0 citations
Review Aug 2026

Dendrimers as Multi-Target Nanotherapeutic Strategies Against Antimicrobial Resistance: Current Drug Targets and Mechanistic Insights

Dendrimers, synthetic, highly branched nanostructures with well-defined architecture and tunable surface functionality, have come as promising multi-target antimicrobial systems that allow dendrimers to overcome multiple bacterial resistance mechanisms simultaneously.

S. Arya, Arshnoor Kaur, Jatin Kaushik et al. · 0 citations
Jul 2026

Cyclic dipeptide-based antimicrobials with potent antibacterial activity.

In bacterial-induced mouse models of epidermal and keratitis infections, cHH8-6 effectively reduces the bacterial count at the infection site with negligible in vivo toxicity, and due to its unique mechanism, cHH8-6 is less likely to induce bacterial resistance compared to clinical antibiotics.

Zhe Zong, Guowenlie Gao, Pengqi Wan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.